Insurers typically argue that regulatory limits on their ability to use genetic tests will induce ‘adverse selection’; they say that this has disadvantages not just for insurers, but also for society as a whole. I argue that, even on its own terms, this argument is often flawed. From the viewpoint of society as a whole, not all adverse selection is adverse. Limits on genetic discrimination that induce the right amount of adverse selection (but not too much adverse selection) can increase ‘loss coverage’, and so make insurance work better for society as a whole
Rapid advances in genetic epidemiology and the setting up of large-scale cohort studies have shifted...
Insurers are rapidly gaining access to consumers’ genetic information. In the US, federal law bars u...
Consumer groups fear that the use of genetic testing information in insurance underwriting might lea...
Insurers typically argue that regulatory limits on their ability to use genetic tests will induce ‘a...
Insurers typically argue that regulatory limits on risk classification will induce ‘adverse selectio...
The use of predictive genetic tests in setting premiums for life insurance is a controversial issue...
Restrictions on insurance risk classification can lead to troublesome adverse selection. A simple ve...
Regulatory restrictions on insurance risk classification are a common feature of personal insurance ...
Insurance underwriting aims to identify risk factors that stratify customers into homogeneous groups...
Insurance has not always been viewed as a corporate behemoth; it was once seen as the basis for a fa...
International audienceThe development of genetic testing creates opportunities to better target dise...
Recent advances in genetics have included the discovery of genes related to disease. There has also...
This paper considers the legal position of genetic test results in insurance law in England and Wale...
The focus of genetics is shifting its contribution to common, complex disorders. New genetic risk fa...
Consumer groups fear that the use of genetic testing information in insurance underwriting might lea...
Rapid advances in genetic epidemiology and the setting up of large-scale cohort studies have shifted...
Insurers are rapidly gaining access to consumers’ genetic information. In the US, federal law bars u...
Consumer groups fear that the use of genetic testing information in insurance underwriting might lea...
Insurers typically argue that regulatory limits on their ability to use genetic tests will induce ‘a...
Insurers typically argue that regulatory limits on risk classification will induce ‘adverse selectio...
The use of predictive genetic tests in setting premiums for life insurance is a controversial issue...
Restrictions on insurance risk classification can lead to troublesome adverse selection. A simple ve...
Regulatory restrictions on insurance risk classification are a common feature of personal insurance ...
Insurance underwriting aims to identify risk factors that stratify customers into homogeneous groups...
Insurance has not always been viewed as a corporate behemoth; it was once seen as the basis for a fa...
International audienceThe development of genetic testing creates opportunities to better target dise...
Recent advances in genetics have included the discovery of genes related to disease. There has also...
This paper considers the legal position of genetic test results in insurance law in England and Wale...
The focus of genetics is shifting its contribution to common, complex disorders. New genetic risk fa...
Consumer groups fear that the use of genetic testing information in insurance underwriting might lea...
Rapid advances in genetic epidemiology and the setting up of large-scale cohort studies have shifted...
Insurers are rapidly gaining access to consumers’ genetic information. In the US, federal law bars u...
Consumer groups fear that the use of genetic testing information in insurance underwriting might lea...